Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Zedsen logo — Creating innovative solutions with non-invasive technology

Zedsen

Creating innovative solutions with non-invasive technology

Founded 2015 United Kingdom London, United Kingdom 22 employees Series B Total: $12.00M Biotechnology, Health Care +1

General Information

Company Name Zedsen
Founded Year 2015
Location United Kingdom London, United Kingdom
Founders / Decision Makers
Team member
Employees 22
Industries Biotechnology, Health Care, Lifestyle
Funding Stage Series B
Business Model B2B, SaaS, B2B2C
Revenue Model Subscription, Usage Based, Leasing/Rental
Offices as of Sep 2026
London, United Kingdom
Social

BounceWatch is an independent company data service, not affiliated with Zedsen. To contact Zedsen, visit zedsen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Zedsen compare?

A PDF of Zedsen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Zedsen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 23, 2026

Zedsen's Alexander Antrobus was featured as a guest on the GS MedTech Podcast, discussing the company's innovative breast health device and industry challenges.

Get alerts when Zedsen shows new signals

About Zedsen

Zedsen, founded in 2015 and headquartered in the United Kingdom, is pioneering the field of non-invasive technology with its proprietary sensor designed to improve health and oncological care. The company aligns with the Institute for Healthcare Improvement’s “Triple Aim”, focused on enhancing the quality of care, improving patient health outcomes, and reducing healthcare costs.

Specializing across Biotechnology, Health Care, and Lifestyle industries, Zedsen presents a compelling proposition for transforming healthcare delivery. Their innovative approach has attracted notable investments, including a $12.00M Series B round completed on 06 April 2021. Prominent investors such as Tony Rice, Nasser J. Kazeminy, James W. Harpel, Bonnie McElveen Hunter, and Joseph Grano have backed the company, reflecting strong confidence in its potential to revolutionize the market.

Business keywords: healthcare optimization, innovative technology, patent-protected sensor, non-invasive solution, oncological services, Institute for Healthcare Improvement, Triple Aim goals, care quality enhancement, patient population health, healthcare cost reduction

Services & Products

Non-ionising breast density and cancer risk assessment
AI-based breast composition measurement
Portable scanning technology for early diagnosis

Target Customers

Primary care clinics Community health centers Healthcare professionals Women, especially with dense breast tissue Health screening organizations

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $12.00M 5
Tony Rice, Nasser J. Kazeminy +3
06 Apr 2021

Zedsen Alternatives & Competitors

View All Alternatives
Zedsen vs
EQRx
EQRx

Redefining the journey from drug discovery to patient care to combat escalating medicine costs throu...

Post-IPO Equity
Biotechnology, Health Care
Zedsen vs
Accelera Innovations
Accelera Innovations

Advanced 21st-century healthcare technology solutions designed to enhance quality, reduce costs, and...

Post-IPO Equity
2-10 employees
Biotechnology, Health Care
Zedsen vs
GlucoSet
GlucoSet Norway

Intensive care monitoring

16 employees
Biotechnology, Health Care
View all alternatives

FAQ About Zedsen

Creating innovative solutions with non-invasive technology
Zedsen was founded in 2015.
Zedsen is headquartered in London, United Kingdom.
Zedsen operates in Biotechnology, Health Care and Lifestyle. Its work centres on healthcare optimization, innovative technology, patent-protected sensor and non-invasive solution. Its customers include Primary care clinics, Community health centers and Healthcare professionals.
Zedsen has a B2B, SaaS and B2B2C business model. Its revenue comes from Subscription, Usage Based and Leasing/Rental.
Zedsen has approximately 22 employees.
Zedsen has completed 1 funding round, raising a total of $12.00M. The latest funding stage is Series B.
Zedsen offers: Non-ionising breast density and cancer risk assessment, AI-based breast composition measurement, Portable scanning technology for early diagnosis.
Top alternatives and competitors to Zedsen include EQRx, Accelera Innovations, GlucoSet, Liberate Medical, ForSight Labs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Zedsen and EQRx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Zedsen, https://bouncewatch.com/company/zedsen, updated 26 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes